Growth in this market is mainly driven by technological advancements, increasing demand for self-injection devices, and the rising incidence of chronic diseases. With the rising geriatric population and the increasing prevalence of chronic diseases, the patient volume has increased significantly globally. This, in turn, is creating a greater demand for advanced and effective treatment approaches, including the use of needle-free injection systems.
The needle-free injection system market is projected to reach USD 272 million by 2026 from USD 124 million in 2021, at a CAGR of 17.0% from 2020 to 2026.
Request for Sample PDF @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=165815861
On the basis of technology, the needle-free injection system market can be segmented into jet-based, spring-based, microarray patches and other injectors. In 2020, the jet-based needle-free injectors segment is expected to command the largest share of 67.4% of the global needle-free injection system devices market by technology. This segment is projected to reach USD 196.9 million by 2026 from USD 71.4 million in 2020, at a CAGR of 18.3% during the forecast period. The large share of this segment can be attributed to benefits associated with this technology, including rapid drug administration, improved dosage accuracy, better diffusion into the tissue, and a faster response rate.
Based on the type, the needle-free injection system market is segmented into liquid-based, powder-based and projectile/depot-based needle-free injectors. The liquid-based segment accounted for the largest share of 70.9% of the needle-free injection system market in 2020. The large share of this segment can be attributed to the ability of a liquid jet, which is stronger enough to penetrate the skin and the underlying fat layer without harming the skin or the integrity of the drug molecule.
Based on site of delivery, the needle-free injection system market is segmented into subcutaneous, intramuscular and intradermal. In 2020, the subcutaneous injectors segment is estimated to account for the largest share of 48% of the needle-free injection system market by the site of delivery. The higher growth of this segment is due to its greater effectiveness as the drug moves into the capillaries when it is injected and from there, it is carried to the bloodstream.
The prominent players in global needle-free injection market include PharmaJet (US), Portal Instruments (US), Medical International Technology, Inc (MIT) (US), NuGen Medical Devices (Canada), Crossject SA (US), and Bioject Medical Technologies (US).
PHARMAJET
PharmaJet held the first position in the needle-free injection system market in 2020. PharmaJet is a leading provider of needle-free injectors. The company has developed PharmaJet Needle-free devices that deliver pharmaceuticals, vaccines, and liquid injectables through the skin, accomplished by the use of jet injection technology. The company’s PharmaJet Needle-free Injector is easy-to-use and eliminates needlestick injuries, needle reuse, and cross-contamination. The company majorly focuses on the inorganic strategies of partnerships and collaborations to enhance its presence in the needle-free injection system market.
Download Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=165815861
North America accounted segment accounted for the largest share in the needle-free injection system market.
On the basis of region, the needle-free injection system market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of 58% of the needle-free injection market, followed by Europe, the Asia Pacific (APAC), Latin America, and the Middle East & Africa. However, the APAC region is expected to grow at the highest CAGR of 18.7% during the forecast period. The rapidly developing healthcare industry in China and India, growth in the aging population, rising life expectancy, rising per capita income, increasing investments in the region by key market players, the expansion of private-sector hospitals & clinics to rural areas, the availability of low-cost labor for manufacturing, the presence of a favorable regulatory environment, and growing demand for self-injectable devices testing are supporting market growth in the APAC region.
Major factors driving the growth of this market include growing prevalence of chronic disease, increasing incidence of communicable disease due to needle stick injuries, rising demand for biosimilars and vaccination, advantages of drug delivery technology, increasing demand for self-injection devices.Key Factors Driving Market Growth:The global needle-free injection system market, in terms of value, is projected to reach USD 20.17 Billion by 2021 from USD 9.81 Billion in 2016, at a CAGR of 15.5% during the forecast period.Revenue Growth Analysis:Growth in this market is mainly driven by growing prevalence of chronic disease, increasing incidence of communicable disease due to needle stick injuries, rising demand for biosimilars and vaccination, advantages of drug delivery technology, increasing demand for self-injection devices.
The report segments the market based on product, technology, type, site of delivery, applications, end user and regions.
Based on the technology, the market is divided into Jet-based needle-free injectors, spring-based needle-free injectors, laser-based needle-free injectors and vibration-based needle-free injectors.
The jet-based needle-free injectors are expected to witness the highest growth during the forecast period, due to their advantages over the other injector systems.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=165815861Based on the technology, the market is divided into Jet-based needle-free injectors, spring-based needle-free injectors, laser-based needle-free injectors and vibration-based needle-free injectors.
The jet-based needle-free injector is expected to account for the largest market share in 2016, due to their advantages over the other injector systems.Based on the Applications, the market is segmented into vaccine delivery, insulin delivery, Oncology, pain management and other applications; the vaccine delivery application segment is projected to be the fastest-growing segment during forecast period in 2016.
The growth of this market primarily attributed to factors such as the rising incidence of chronic diseases, technological advancement, and growing preference for self-medication.Based on the end user, the market is segmented into Hospitals and Clinics, home care settings, research laboratories, pharmaceutical and biotechnological companies and other end user.
Major factors driving the growth of this market include growing prevalence of chronic disease, increasing incidence of communicable disease due to needle stick injuries, rising demand for biosimilars and vaccination, advantages of drug delivery technology, increasing demand for self-injection devices.
On the other hand, high development cost of needle-free injection system over the conventional needle injection may hinder the growth of this market during the forecast period.
The report segments the market based on product, technology, type, site of delivery, applications, end user and regions.The global needle-free injection system market, in terms of value, is projected to reach USD 20.17 Billion by 2021 from USD 9.81 Billion in 2016, at a CAGR of 15.5% during the forecast period.Growth in this market is mainly driven by growing prevalence of chronic disease, increasing incidence of communicable disease due to needle stick injuries, rising demand for biosimilars and vaccination, advantages of drug delivery technology, increasing demand for self-injection devices.
On the other hand, high development cost of needle-free injection systems over the conventional needle injection may hinder the growth of this market during the forecast period.Market DynamicsGrowing Prevalence of Chronic DiseasesIncreasing Incidence of Communicable Diseases Due to Needlestick InjuriesRise in Demand for Self-Injection DevicesBased on the Applications, the market is segmented into vaccine delivery, insulin delivery, Oncology, pain management and other applications; the vaccine delivery application segment is projected to be the fastest-growing segment during forecast period in 2016.
The growth of this market primarily attributed to factors such as the rising incidence of chronic diseases, technological advancement, and growing preference for self-medication.Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=165815861Based on the technology, the market is divided into Jet-based needle-free injectors, spring-based needle-free injectors, laser-based needle-free injectors and vibration-based needle-free injectors.
The jet-based needle-free injector is expected to account for the largest market share in 2016, due to their advantages over the other injector systems.The geographical regions mapped in the report are:1.
The global needle free injection market size is expected to touch USD 25,057.4 million by 2023 owing to a high prevalence of diabetes and chronic diseases.
Market Research Future’s (MRFR) latest study reveals that the market is predicted a 15.28 % CAGR during the forecast period (2018–2023).
Needle free injections are medical devices which deliver drugs directly via the skin instead of using hypodermic needles as a medium.
By product type, the market has been segmented into fillable and prefilled needle free injectors.
Technologies covered in the report include laser-powered, jet-based, and spring-based.
Among these, the jet-based segment can touch a size of USD 10,391.3 million by 2023 owing to a faster method of delivery as compared to other technologies.
Global Needle Free Injection Market Research Report information: Product (Fillable) Technology (Jet-Based) Usability (Reusable), Type of Medication (Liquid-Based), Site of Delivery (Intra dermal), Application (Vaccination) End Users (Hospitals) – Forecast Till 2023Market Highlights:The global needle free injection market size is expected to touch USD 25,057.4 million by 2023 owing to high prevalence of diabetes and chronic diseases.
Increasing use of these injections by patients owing to its accurate dosage, pain relief, and low risks can lead to high market demand in the coming years.
But high costs of these medical devices can pose a challenge to market growth.Avail a Free Sample@ https://www.marketresearchfuture.com/sample_request/6180Global Market for Needle Free Injection – Segmental AnalysisMRFR’s report offers a detailed segmental analysis of the market based on product, technology, usability, type of medication, site of delivery, application, and end-user.
The liquid-based segment held a large share of the market in 2017.
The intramuscular segment is touted to generate maximum revenue for the needle free injection market owing to muscles absorbing vaccines at a much higher rate as compared to veins.Applications include oncology, vaccination, and insulin delivery.
Major market end-users include hospitals and clinics, ambulatory surgical centers, and homecare settings.
